|
TOP NEWS
AstraZeneca Unit Ducks Patent Fraud, Not Sham Suit Claims
By Bryan Koenig
A Massachusetts federal judge spared AstraZeneca unit Alexion on Friday from half of a nonprofit insurer's proposed class action, finding the plaintiff too far removed from anticompetitive patent fraud that allegedly propped up blood disorder treatment Soliris, while preserving accusations that Alexion brought sham infringement allegations against would-be rivals.
Opinion attached |
Read full article »
| Save to favorites »
LITIGATION
DEALS
BANKRUPTCY
PEOPLE
EXPERT ANALYSIS
LEGAL INDUSTRY
Roundup
UK Litigation Roundup: Here's What You Missed In London
By Laura Stewart Liberty
This past week in London has seen the designer of an 88-facet diamond bring a copyright claim against a luxury watch retailer, collapsed firm Axiom Ince bring legal action against the solicitors' watchdog, and the Post Office hit with compensation claims from two former branch managers over their wrongful convictions during the Horizon information technology scandal.
Read full article »
| Save to favorites »
|